Sensus Healthcare (SRTS) Liabilities and Shareholders Equity (2015 - 2026)
Sensus Healthcare (SRTS) recorded quarterly Liabilities and Shareholders Equity of $51.5 million in Q1 2026, down 2.81% quarter-over-quarter from $53.0 million in Q4 2025, and down 14.39% on a YoY basis from $60.2 million in Q1 2025.
Sensus Healthcare (SRTS) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
Sensus Healthcare's Liabilities and Shareholders Equity history runs 12 years deep, the most recent figure standing at $51.5 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 14.39% year-over-year to $51.5 million; the TTM figure through Mar 2026 stood at $221.7 million (down 7.76% YoY), while the FY2025 annual figure was $53.0 million, down 14.68% from the prior year.
- Liabilities and Shareholders Equity was $51.5 million for Q1 2026 at Sensus Healthcare, down from $53.0 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $62.2 million in Q4 2024 to a low of $50.5 million in Q3 2023.
- Historically, Liabilities and Shareholders Equity has averaged $55.9 million across 5 years, with a median of $56.3 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity surged 113.75% in 2022, then slipped 14.68% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $56.7 million in 2022, then dropped by 5.33% to $53.7 million in 2023, then rose by 15.74% to $62.2 million in 2024, then decreased by 14.68% to $53.0 million in 2025, then fell by 2.81% to $51.5 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $51.5 million (Q1 2026), $53.0 million (Q4 2025), and $58.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Sensus Healthcare | 45.77 Mn | 27.44 Mn | - | 51.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.55 Mn |
| Dec 31, 2025 | 53.04 Mn |
| Sep 30, 2025 | 58.30 Mn |
| Jun 30, 2025 | 58.85 Mn |
| Mar 31, 2025 | 60.21 Mn |
| Dec 31, 2024 | 62.17 Mn |
| Sep 30, 2024 | 59.86 Mn |
| Jun 30, 2024 | 58.16 Mn |
| Mar 31, 2024 | 57.27 Mn |
| Dec 31, 2023 | 53.71 Mn |
| Sep 30, 2023 | 50.55 Mn |
| Jun 30, 2023 | 52.02 Mn |
| Mar 31, 2023 | 53.40 Mn |
| Dec 31, 2022 | 56.74 Mn |
| Sep 30, 2022 | 54.76 Mn |
| Jun 30, 2022 | 56.35 Mn |
| Mar 31, 2022 | 53.93 Mn |
| Dec 31, 2021 | 32.24 Mn |
| Sep 30, 2021 | 25.63 Mn |
| Jun 30, 2021 | 26.36 Mn |